Antibody-dependent enhancement of dengue virus infection is inhibited by SA-17, a doxorubicin derivative

Antiviral Research

Volumn 100, Issue 1, 2013, Pages 238-245

  Ayala Nuñez, Nilda V ^a   Jarupathirun, Patsaporn ^a   Kaptein, Suzanne J F ^b   Neyts, Johan ^b   Smit, Jolanda M ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

Antibody dependent enhancement; Dengue virus; Doxorubicin derivative

Indexed keywords

ANTIVIRUS AGENT; DOXORUBICIN DERIVATIVE; SA 17; UNCLASSIFIED DRUG; DOXORUBICIN; DRUG DERIVATIVE; VIRUS ANTIBODY;

ANIMAL CELL; ANTIBODY DEPENDENT ENHANCEMENT; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DENGUE; DENGUE VIRUS; DENGUE VIRUS 2; IMMATURE VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SECONDARY INFECTION; DRUG EFFECT; HUMAN; IMMUNOLOGY; PHYSIOLOGY; VIROLOGY; VIRUS REPLICATION;

DENGUE VIRUS; YELLOW FEVER VIRUS;

ANTIBODY-DEPENDENT ENHANCEMENT; DENGUE VIRUS; DOXORUBICIN DERIVATIVE;

ANTIBODIES, VIRAL; ANTIBODY-DEPENDENT ENHANCEMENT; ANTIVIRAL AGENTS; DENGUE; DENGUE VIRUS; DOXORUBICIN; HUMANS; VIRUS REPLICATION;

EID: 84883701961     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2013.08.013     Document Type: Article

References (43)

1. M.M. Alen, and D. Schols Dengue virus entry as target for antiviral therapy J. Trop. Med. 2012 2012 628475 10.1155/2012/628475
2. M.M. Alen, S.J. Kaptein, T. De Burghgraeve, J. Balzarini, J. Neyts, and D. Schols Antiviral activity of carbohydrate-binding agents and the role of DC-SIGN in dengue virus infection Virology 387 2009 67 75 10.1016/j.virol.2009. 01.043
3. N.V. Ayala-Nunez, J. Wilschut, and J.M. Smit Monitoring virus entry into living cells using DiD-labeled dengue virus particles Methods 55 2011 137 143 10.1016/j.ymeth.2011.07.009
4. J.E. Cardier, E. Marino, E. Romano, P. Taylor, F. Liprandi, N. Bosch, and A.L. Rothman Proinflammatory factors present in sera from patients with acute dengue infection induce activation and apoptosis of human microvascular endothelial cells: possible role of TNF-alpha in endothelial cell damage in dengue Cytokine 30 2005 359 365 10.1016/j.cyto.2005.01.021 (Pubitemid 40780968)
5. J.M. Costin, E. Jenwitheesuk, S.M. Lok, E. Hunsperger, K.A. Conrads, K.A. Fontaine, C.R. Rees, M.G. Rossmann, S. Isern, R. Samudrala, and S.F. Michael Structural optimization and de novo design of dengue virus entry inhibitory peptides PLoS Negl. Trop. Dis. 4 2010 e721 10.1371/journal.pntd.0000721
6. J.M. da Silva Voorham, I.A. Rodenhuis-Zybert, N.V. Ayala Nunez, T.M. Colpitts, H. van der Ende-Metselaar, E. Fikrig, M.S. Diamond, J. Wilschut, and J.M. Smit Antibodies against the envelope glycoprotein promote infectivity of immature dengue virus serotype 2 PLoS ONE 7 2012 e29957 10.1371/journal.pone. 0029957
7. W. Dejnirattisai, A. Jumnainsong, N. Onsirisakul, P. Fitton, S. Vasanawathana, W. Limpitikul, C. Puttikhunt, C. Edwards, T. Duangchinda, S. Supasa, K. Chawansuntati, P. Malasit, J. Mongkolsapaya, and G. Screaton Cross-reacting antibodies enhance dengue virus infection in humans Science 328 2010 745 748 10.1126/science.1185181
8. M.S. Diamond, D. Edgil, T.G. Roberts, B. Lu, and E. Harris Infection of human cells by dengue virus is modulated by different cell types and viral strains J. Virol. 74 2000 7814 7823 (Pubitemid 30641625)
9. M.G. Guzman, and S. Vazquez The complexity of antibody-dependent enhancement of dengue virus infection Viruses 2 2010 2649 2662 10.3390/v2122649
10. S.B. Halstead Dengue Lancet 370 2007 1644 1652 10.1016/S0140-6736(07) 61687-0 (Pubitemid 350052290)
11. S.B. Halstead Neutralization and antibody-dependent enhancement of dengue viruses Adv. Virus Res. 60 2003 421 467 (Pubitemid 137639381)
12. S.B. Halstead, K. Larsen, S. Kliks, J.S. Peiris, J. Cardosa, and J.S. Porterfield Comparison of P388D1 mouse macrophage cell line and human monocytes for assay of dengue-2 infection-enhancing antibodies Am. J. Trop. Med. Hyg. 32 1983 157 163 (Pubitemid 13186852)
13. S.B. Halstead, and E.J. O'Rourke Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody J. Exp. Med. 146 1977 201 217 (Pubitemid 8139503)
14. E.A. Henchal, M.K. Gentry, J.M. McCown, and W.E. Brandt Dengue virus-specific and flavivirus group determinants identified with monoclonal antibodies by indirect immunofluorescence Am. J. Trop. Med. Hyg. 31 1982 830 836 (Pubitemid 12041595)
15. K.J. Huang, Y.C. Yang, Y.S. Lin, J.H. Huang, H.S. Liu, T.M. Yeh, S.H. Chen, C.C. Liu, and H.Y. Lei The dual-specific binding of dengue virus and target cells for the antibody-dependent enhancement of dengue virus infection J. Immunol. 176 2006 2825 2832
16. J. Junjhon, T.J. Edwards, U. Utaipat, V.D. Bowman, H.A. Holdaway, W. Zhang, P. Keelapang, C. Puttikhunt, R. Perera, P.R. Chipman, W. Kasinrerk, P. Malasit, R.J. Kuhn, and N. Sittisombut Influence of pr-M cleavage on the heterogeneity of extracellular dengue virus particles J. Virol. 84 2010 8353 8358 10.1128/JVI.00696-10
17. S.J. Kaptein, T. De Burghgraeve, M. Froeyen, B. Pastorino, M.M. Alen, J.A. Mondotte, P. Herdewijn, M. Jacobs, X. de Lamballerie, D. Schols, A.V. Gamarnik, F. Sztaricskai, and J. Neyts A derivate of the antibiotic doxorubicin is a selective inhibitor of dengue and yellow fever virus replication in vitro Antimicrob. Agents Chemother. 54 2010 5269 5280 10.1128/AAC.00686-10
18. E. Lee, M. Pavy, N. Young, C. Freeman, and M. Lobigs Antiviral effect of the heparan sulfate mimetic, PI-88, against dengue and encephalitic flaviviruses Antiviral Res. 69 2006 31 38 10.1016/j.antiviral.2005.08.006 (Pubitemid 41790479)
19. L. Li, S.M. Lok, I.M. Yu, Y. Zhang, R.J. Kuhn, J. Chen, and M.G. Rossmann The flavivirus precursor membrane-envelope protein complex: structure and maturation Science 319 2008 1830 1834 10.1126/science.1153263 (Pubitemid 351451591)
20. Y. Modis, S. Ogata, D. Clements, and S.C. Harrison A ligand-binding pocket in the dengue virus envelope glycoprotein Proc. Natl. Acad. Sci. USA 100 2003 6986 6991 10.1073/pnas.0832193100 (Pubitemid 36706380)
21. D.M. Morens, S.B. Halstead, and N.J. Marchette Profiles of antibody-dependent enhancement of dengue virus type 2 infection Microb. Pathog. 3 1987 231 237
22. S. Mukhopadhyay, R.J. Kuhn, and M.G. Rossmann A structural perspective of the flavivirus life cycle Nat. Rev. Microbiol. 3 2005 13 22 10.1038/nrmicro1067 (Pubitemid 40028466)
23. C.O. Nicholson, J.M. Costin, D.K. Rowe, L. Lin, E. Jenwitheesuk, R. Samudrala, S. Isern, and S.F. Michael Viral entry inhibitors block dengue antibody-dependent enhancement in vitro Antiviral Res. 89 2011 71 74 10.1016/j.antiviral.2010.11.008
24. H. Ochiai, M. Kurokawa, K. Hayashi, and S. Niwayama Antibody-mediated growth of influenza A NWS virus in macrophagelike cell line P388D1 J. Virol. 62 1988 20 26 (Pubitemid 18050787)
25. L. Ono, W. Wollinger, I.M. Rocco, T.L. Coimbra, P.A. Gorin, and M.R. Sierakowski In vitro and in vivo antiviral properties of sulfated galactomannans against yellow fever virus (BeH111 strain) and dengue 1 virus (Hawaii strain) Antiviral Res. 60 2003 201 208 (Pubitemid 37456868)
26. A.P. Rathore, P.N. Paradkar, S. Watanabe, K.H. Tan, C. Sung, J.E. Connolly, J. Low, E.E. Ooi, and S.G. Vasudevan Celgosivir treatment misfolds dengue virus NS1 protein, induces cellular pro-survival genes and protects against lethal challenge mouse model Antiviral Res. 92 2011 453 460 10.1016/j.antiviral.2011.10.002
27. I.A. Rodenhuis-Zybert, H.M. van der Schaar, J.M. da Silva Voorham, H. van der Ende-Metselaar, H.Y. Lei, J. Wilschut, and J.M. Smit Immature dengue virus: a veiled pathogen? PLoS Pathog. 6 2010 e1000718 10.1371/journal.ppat.1000718
28. A. Sabchareon, D. Wallace, C. Sirivichayakul, K. Limkittikul, P. Chanthavanich, S. Suvannadabba, V. Jiwariyavej, W. Dulyachai, K. Pengsaa, T.A. Wartel, A. Moureau, M. Saville, A. Bouckenooghe, S. Viviani, N.G. Tornieporth, and J. Lang Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial Lancet 2012 10.1016/S0140-6736(12)61428-7; 10.1016/S0140-6736(12) 61428-7
29. C.P. Simmons, J.J. Farrar, v.V. Nguyen, and B. Wills Dengue N. Engl. J. Med. 366 2012 1423 1432 10.1056/NEJMra1110265; 10.1056/NEJMra1110265
30. J.R. Stephenson Understanding dengue pathogenesis: implications for vaccine design Bull. World Health Organ. 83 2005 308 314 doi: /S0042-96862005000400016. (Pubitemid 40529628)
31. J.R. Stephenson The problem with dengue Trans. R. Soc. Trop. Med. Hyg. 99 2005 643 646 10.1016/j.trstmh.2005.05.003 (Pubitemid 40945752)
32. S. Sukupolvi-Petty, S.K. Austin, M. Engle, J.D. Brien, K.A. Dowd, K.L. Williams, S. Johnson, R. Rico-Hesse, E. Harris, T.C. Pierson, D.H. Fremont, and M.S. Diamond Structure and function analysis of therapeutic monoclonal antibodies against dengue virus type 2 J. Virol. 84 2010 9227 9239 10.1128/JVI.01087-10
33. S.S. Sung Phagocytosis by mouse peritoneal macrophages plated on monoclonal antibody-coated immune complex-substrates: effects of complexes of different IgG subclasses on Fc receptor functions J. Immunol. 135 1985 1981 1986
34. F. Sztaricskai, A. Sum, E. Roth, I.F. Pelyvas, S. Sandor, G. Batta, P. Herczegh, J. Remenyi, Z. Miklan, and F. Hudecz A new class of semisynthetic anthracycline glycoside antibiotics incorporating a squaric acid moiety J. Antibiot. (Tokyo) 58 2005 704 714 10.1038/ja.2005.96 (Pubitemid 43002086)
35. P.R. Twentyman, and M. Luscombe A study of some variables in a tetrazolium dye (MTT) based assay for cell growth and chemosensitivity Br. J. Cancer 56 1987 279 285 (Pubitemid 17158816)
36. H.M. van der Schaar, M.J. Rust, C. Chen, H. van der Ende-Metselaar, J. Wilschut, X. Zhuang, and J.M. Smit Dissecting the cell entry pathway of dengue virus by single-particle tracking in living cells PLoS Pathog. 4 2008 e1000244 10.1371/journal.ppat.1000244
37. H.M. van der Schaar, M.J. Rust, B.L. Waarts, H. van der Ende-Metselaar, R.J. Kuhn, J. Wilschut, X. Zhuang, and J.M. Smit Characterization of the early events in dengue virus cell entry by biochemical assays and single-virus tracking J. Virol. 81 2007 12019 12028 10.1128/JVI.00300-07 (Pubitemid 47623832)
38. Q.Y. Wang, S.J. Patel, E. Vangrevelinghe, H.Y. Xu, R. Rao, D. Jaber, W. Schul, F. Gu, O. Heudi, N.L. Ma, M.K. Poh, W.Y. Phong, T.H. Keller, E. Jacoby, and S.G. Vasudevan A small-molecule dengue virus entry inhibitor Antimicrob. Agents Chemother. 53 2009 1823 1831 10.1128/AAC.01148-08
39. K. Whitby, T.C. Pierson, B. Geiss, K. Lane, M. Engle, Y. Zhou, R.W. Doms, and M.S. Diamond Castanospermine, a potent inhibitor of dengue virus infection in vitro and in vivo J. Virol. 79 2005 8698 8706 10.1128/JVI.79.14.8698-8706. 2005 (Pubitemid 40934780)
40. World Health Organization, 2012. Dengue and severe dengue, Fact sheet N 117. 2012.
41. World Health Organization, DengueNet. 2012.
42. S.F. Wu, C.J. Lee, C.L. Liao, R.A. Dwek, N. Zitzmann, and Y.L. Lin Antiviral effects of an iminosugar derivative on flavivirus infections J. Virol. 76 2002 3596 3604 (Pubitemid 34250524)
43. I.A. Zybert, H. van der Ende-Metselaar, J. Wilschut, and J.M. Smit Functional importance of dengue virus maturation: infectious properties of immature virions J. Gen. Virol. 89 2008 3047 3051 10.1099/vir.0.2008/002535-0